div.javascriptErrorPage { background-color: rgba(0,0,0,0.3); width: 100%; text-align: center; height: 100vh; } div.javascriptErrorPageContent { position: fixed; top : 50%; left: 50%; -ms-transform: translate(-50%, -50%); transform : translate(-50%, -50%); border-radius: 20px; background: #FFFFFF; box-shadow: 0px 3px 5px rgba(0, 0, 0, 0.2), 0px 6px 10px rgba(0, 0, 0, 0.14), 0px 1px 18px rgba(0, 0, 0, 0.12); } /* This is mobile */ @media (max-width:600px) { div.javascriptErrorPage { background-color: none; width: 100%; text-align: center; height: auto; } div.javascriptErrorPageContent { width: 100%; border-radius: none; box-shadow: none; } }

JavaScript required

We’re sorry, but WorldCat does not work without JavaScript enabled. Please enable JavaScript on your browser.

ผ่านการประเมินคุณภาพแล้ว

The Economic Conundrum for Antibacterial Drugs

ผู้แต่ง:David M. Shlaes

บทสรุป:While resistance to antibacterial drugs is increasing globally, it is unevenly distributed. The number of cases that are truly difficult to treat remain below the number required to drive an adequate market for needed new therapies. Without a sufficient market, companies pursuing these drugs risk financial failure. Here, I explore, at least briefly, the current situation and the financial risks to companies. I provide potential solutions to the failed market

บทความ, 2019